October 12, 2022
  • Walgreens Boots Alliance (WBA) announced it entered into a definitive agreement to acquire the remaining 45 percent stake in CareCentrix. WBA initially announced a $330 million investment in CareCentrix in October of 2021. At the time of the deal, WBA gained a 55 percent stake in CareCentrix, with an option to buy the remaining equity interests. CareCentrix CEO John Driscoll will join WBA to lead U.S. health care, including Walgreens Health. The deal is expected to be finalized in March of 2023. (Press release here; Article here)